References for: association

Full identifier: http://purl.org/np/RAsHDv8Y8z6E7xT3kU5fCHi8stP8BzVAcFjwpxxmpwpQM#association

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Citalopram proved to be effective in the treatment of OCD [55], with best results at doses of 60 mg/day [56], which correlated with improvements on psychosocial functioning, depressive symptoms, obsessive thoughts, repetitive behavior, and anxiety. It showed good tolerability [57] and appeared to be effective in patients with refractory OCD [58].
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Vincent Emonet
2022-09-16T11:53:44.420Z